Chemical structure of molecule ACT-1004-1239

CXCR7 GPCR insurmountable antagonist

target engagement in rodent, 61% F in dog

from 300k HTS vs. _-arrestin recruitment, opt.

J. Med. Chem., Dec. 14, 2020

Idorsia Pharma (Actelion), Allschwil, CH

Idorsia/Actelion CXCR7 GPCR insurmountable antagonist


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.